argenx SE at JPMorgan Healthcare Conference (Virtual) Transcript
Great. Good morning, good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, it gives me great pleasure to introduce Tim Van Hauwermeiren, CEO of argenx for this presentation. Timely, too, for argenx, give all the progress made since we last heard from the company a year ago and also recent updates last week.
So today, we can have a 20-minute presentation from Tim, and then we'll have 20 minutes for questions. I will also have argenx COO, Keith Woods, join us for the Q&A. (Operator Instructions)
So with that said, welcome, Tim, to the conference and looking forward to the presentation.
Thank you, James. Thank you very much for having us. And I would like to start with the first slide on the forward-looking statements, please, to draw your attention for 1 minute to these statements.
Okay. So next slide, please Slide #3. Good morning, and thank you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
